mpt64 Resolved · medium auto-curated

H37Rv Rv1980c · MTBC0 mtbc0_002102 · 228 aa · 2246956–2247642 MTBC0 (-) · RefSeq NP_216496.1

Genomic neighbourhood (genome browser)

Open in full genome browser →

This gene (outlined) in its genomic context; arrows are neighbouring genes coloured by verdict. Click any gene to navigate. Pan and zoom in the full browser.

Annotation: from legacy to revised

Legacy (H37Rv / Mycobrowser)immunogenic protein Mpt64
MTBC0 PGAP re-annotationimmunoprotective protein Mpt64
Revised (this work)Immunoprotective protein Mpt64.
Functional category (TubercuList)cell wall and cell processes

Auto-curated: this verdict and function were generated by rules from PGAP + Pfam + Foldseek and have not been hand-reviewed.

In the literature (TB corpus sweep) 368 publications

368 TB publications mention this gene. 368 publications discuss this gene. Queried separately, 362 records carry a M. tuberculosis context and 20 a non-TB mycobacterial context (species named in the 20-record verified sample: M. abscessus (12), M. leprae (4), M. smegmatis (3), M. marinum (1)). The three counts come from three distinct PubMed queries (each with its own context filter), so they neither partition the total nor need to add up to it.

5 of 368: the most recently indexed records of the curated sweep at its date, not necessarily the most recent papers on this gene — the exhaustive list below is later and broader and may hold newer ones.
PublicationDate
From immunoinformatics insights to assay development: establishment of a peptide-based indirect elisa for cynomolgus tuberculosis detection. doi:10.3389/fcimb.2026.1799877 2026
Advances in electrochemical immunosensors for tuberculosis detection: a systematic review. doi:10.1016/j.btre.2026.e00967 2026
Performance and Cost-Efficiency of an MPT64 Assay for Detecting Mycobacterium tuberculosis Complex in a Setting With Frequent Nontuberculous Mycobacteria Isolation. doi:10.3346/jkms.2026.41.e9 2026
Detection of Mycobacterium tuberculosis antigens in urinary extracellular vesicles using real-time immuno-PCR: A non-invasive diagnostic approach for pulmonary tuberculosis. doi:10.1038/s41598-026-55896-w 2026
Stepwise PEG Precipitation Coupled with Hydrophobic Interaction Chromatography Enables the Production of Highly Specific Anti-Ag85B IgY for Tuberculosis Immunodiagnostics. doi:10.2147/IDR.S610371 2026
380 records returned by the alias sweep (a separate sweep from the 368 above; both are shown, neither is exhaustive)

Searched as: Rv1980c, mpt64, Mb2002c, MMAR_5409, MAB_1835c — each in conjunction with a mycobacterial context term. Swept 2026-09-07.

PublicationJournalYear
From host response to genomic targets: electrochemical biosensing of tuberculosis biomarkers. doi:10.1016/j.bioelechem.2026.109438 Bioelectrochemistry 2027
Development of Stable Nanosubstrates Using ZnO Nanoparticle-Embedded Polymer Composites for Sensitive Detection of MPT64 Antigens. doi:10.1021/acsabm.6c00911 names it ACS Appl Bio Mater 2026
Rapid Triage of Smear-Positive Tuberculosis Suspects with a Commercial DNA Microarray: A Real-World Experience from 1100 Sputum Specimens. doi:10.2147/IDR.S623608 Infect Drug Resist 2026
Analytical performance of a multi-target open real-time PCR assay for simultaneous detection of tuberculosis, non-tuberculous mycobacteria, and drug resistance in a high-burden setting. doi:10.1128/spectrum.01643-26 Microbiol Spectr 2026
Subspecies Identification and Characterization of Drug Resistance and Virulence Factors in Clinical Strains of Mycobacterium abscessus Complex Isolated from South India. doi:10.3390/idr18040073 Infect Dis Rep 2026
From immunoinformatics insights to assay development: establishment of a peptide-based indirect elisa for cynomolgus tuberculosis detection. doi:10.3389/fcimb.2026.1799877 Front Cell Infect Microbiol 2026
Advances in electrochemical immunosensors for tuberculosis detection: a systematic review. doi:10.1016/j.btre.2026.e00967 Biotechnol Rep (Amst) 2026
Performance and Cost-Efficiency of an MPT64 Assay for Detecting Mycobacterium tuberculosis Complex in a Setting With Frequent Nontuberculous Mycobacteria Isolation. doi:10.3346/jkms.2026.41.e9 names it J Korean Med Sci 2026
Detection of Mycobacterium tuberculosis antigens in urinary extracellular vesicles using real-time immuno-PCR: A non-invasive diagnostic approach for pulmonary tuberculosis. doi:10.1038/s41598-026-55896-w Sci Rep 2026
Stepwise PEG Precipitation Coupled with Hydrophobic Interaction Chromatography Enables the Production of Highly Specific Anti-Ag85B IgY for Tuberculosis Immunodiagnostics. doi:10.2147/IDR.S610371 Infect Drug Resist 2026
Rapid detection of Mycobacterium tuberculosis based on aptamer modified surface-enhanced Raman scattering biosensors. doi:10.1016/j.saa.2026.128122 Spectrochim Acta A Mol Biomol Spectrosc 2026
Safety, tolerability, and concordance with interferon-γ release assays of a recombinant ESAT6-MPT64 skin test: a phase 1 randomized clinical trial. doi:10.3389/fimmu.2026.1780294 names it Front Immunol 2026
Correction: Safety, tolerability, and concordance with interferon-γ release assays of a recombinant ESAT6-MPT64 skin test: a phase 1 randomized clinical trial. doi:10.3389/fimmu.2026.1863033 names it Front Immunol 2026
Molecular detection of incidental Mycobacterium tuberculosis and nontuberculous mycobacteria co-detections using DNA strip assay: a laboratory-based study. doi:10.1038/s41598-026-52768-1 Sci Rep 2026
Identification and drug resistance profiling of Mycobacterium orygis from an African elephant using whole-genome sequencing. doi:10.1128/spectrum.03586-25 Microbiol Spectr 2026
A multilayer 2D material plasmonic metasurface terahertz biosensor with machine learning optimization for high-sensitivity tuberculosis detection. doi:10.1016/j.saa.2026.127847 Spectrochim Acta A Mol Biomol Spectrosc 2026
Diagnostic Aspects of a Bacillus Calmette-Guërin (BCG) Infection Following Intravesical Treatment for Bladder Cancer. doi:10.7754/Clin.Lab.2025.250644 Clin Lab 2026
Frequency, genetic mechanisms and factors associated with fluoroquinolone (pre-XDR) and aminoglycoside resistance among multidrug-resistant tuberculosis cases in Northwestern Nigeria. doi:10.1186/s12879-026-13191-z BMC Infect Dis 2026
MPT64 antigen-induced immune responses as a novel diagnostic tool for tuberculosis. doi:10.1128/spectrum.03381-24 names it Microbiol Spectr 2026
Identifying missing links - an ongoing outbreak of a novel tuberculosis strain in regional Queensland. doi:10.33321/cdi.2026.50.019 Commun Dis Intell (2018) 2026
Targeted detection of Mycobacterium tuberculosis MPT64 antigen using an antibody-coated nanoporous anodic alumina biosensor: A novel approach for tuberculosis screening. doi:10.1016/j.talanta.2026.129625 names it Talanta 2026
The Mycobacterium tuberculosis specific antigen MPT64 in BALF has potential diagnostic value in the diagnosis of pulmonary tuberculosis. doi:10.3389/fmed.2026.1726316 names it Front Med (Lausanne) 2026
False-positive Bioline TB Ag MPT64 result from MGIT bottles inoculated with Staphylococcus aureus. doi:10.1128/jcm.01711-25 names it J Clin Microbiol 2026
Scalable extracellular expression of tag-free MPT64 protein in E. coli via pelB signal optimization: a step toward tuberculosis diagnostic antigen preparation. doi:10.1080/10826068.2025.2551369 names it Prep Biochem Biotechnol 2026
Evaluation of Xpert MTB/Rif Versus Mycobacterium Growth Indicator Tube 960 for Rifampicin Resistance Detection in Extrapulmonary Isolates. doi:10.4103/ijmy.ijmy_169_25 Int J Mycobacteriol 2025
An Uncommon Site, a Common Foe: Isolated Hepatic Tuberculosis in a HIV Positive Adult. doi:10.7759/cureus.96553 Cureus 2025
Diagnostic performance of two commercial MPT64 assays for the identification of Mycobacterium tuberculosis complex from liquid culture. doi:10.1016/j.ijtb.2023.12.007 names it Indian J Tuberc 2025
Simultaneous and sensitive detection of Mycobacterium tuberculosis and SARS-CoV-2 antigens employing an electrochemical impedance spectroscopy aptasensor. doi:10.3389/fbioe.2025.1692839 Front Bioeng Biotechnol 2025
Response to "Correspondence on 'Utility of pleural fluid-derived extracellular vesicles as a source of Mycobacterium tuberculosis antigens MPT51 and MPT64 for pleural TB diagnosis: a proof-of-concept study". doi:10.1016/j.tube.2025.102699 names it Tuberculosis (Edinb) 2025
Challenges and Potential of Antibody-Drug Conjugates as Prospective Tuberculosis Therapeutics. doi:10.3390/microorganisms13102234 Microorganisms 2025
Letter to Editor: manuscript entitled "Utility of pleural fluid-derived extracellular vesicles as a source of Mycobacterium tuberculosis antigens MPT51 and MPT64 for pleural TB diagnosis: a proof-of-concept study" by Jindal et al. published in Tuberculosis150 (2025) 102578. doi:10.1016/j.tube.2025.102695 names it Tuberculosis (Edinb) 2025
Expression of a Tuberculosis-Associated Immunogenic Protein in Escherichia coli. doi:10.3390/life15091472 Life (Basel) 2025
Advancing Extrapulmonary Tuberculosis Diagnosis: Potential of MPT64 Immunochemistry-Based Antigen Detection Test in a High-TB, Low-HIV Endemic Setting. doi:10.3390/pathogens14080741 names it Pathogens 2025
Immunoinformatics analysis of the proteins MPT83 and MPT51 to design a possible chimeric vaccine against Mycobacterium tuberculosis. doi:10.1007/s42770-025-01755-1 Braz J Microbiol 2025
Clinical Presentations and Species Spectrum of Nontuberculous Mycobacteria in Suspected Pulmonary Tuberculosis Cases. doi:10.4103/jgid.jgid_152_24 J Glob Infect Dis 2025
Role of Immunocytochemistry in Detection of Mycobacterium tuberculosis Antigen by Fine Needle Aspiration Cytology. doi:10.4103/joc.joc_37_24 J Cytol 2025
The accuracy of Mycobacterium tuberculosis complex identification using cording observation with mpt64 antigen as the reference standard. doi:10.1016/j.diagmicrobio.2025.116927 names it Diagn Microbiol Infect Dis 2025
Development of DNA aptamers towards detection of tuberculosis biomarker Ag85B in a fluorescence-based sensing platform. doi:10.1016/j.aca.2025.344029 Anal Chim Acta 2025
Identification of Nontuberculous Mycobacteria in Patients with Multidrug-resistant Tuberculosis in Quezon City, Philippines, Using Multiplex PCR. doi:10.47895/amp.v59i4.9049 Acta Med Philipp 2025
Prediction of a novel synthetic peptide vaccine against tuberculosis and validation of its immunogenicity. doi:10.1016/j.intimp.2025.114531 Int Immunopharmacol 2025
Validation study of a novel, rapid, open platform real-time LAMP assay for early diagnosis of pulmonary tuberculosis. doi:10.1038/s41598-025-93565-6 Sci Rep 2025
mpt64 mutations in Mycobacterium tuberculosis with negative MPT64 antigen assay results from a tertiary hospital in Southeastern China. doi:10.3389/fmed.2025.1531853 names it Front Med (Lausanne) 2025
Graphene Oxide-Assisted Tapered Microfiber Super-Sensor for Rapid Detection of Mycobacterium tuberculosis Antigens. doi:10.1002/bit.28929 Biotechnol Bioeng 2025
Quantification of MPT-64 within pleural fluid extracellular vesicles of tuberculous pleurisy patients by real-time immuno-PCR. doi:10.1016/j.ab.2025.115829 Anal Biochem 2025
Immunogenicity and protective efficacy of a multi-antigenic adenovirus-based vaccine candidate against Mycobacterium tuberculosis. doi:10.3389/fmicb.2025.1492268 Front Microbiol 2025
Identifying plasma exosome antigens as a potential diagnostic biomarker for tuberculosis disease. doi:10.1186/s12879-025-10474-9 BMC Infect Dis 2025
Development and assessment of a novel magnetic nanoparticle antibody-conjugate and aptamer-based assay (MNp-Ab-Ap assay) for the rapid diagnosis of pleural tuberculosis. doi:10.7150/ntno.95332 Nanotheranostics 2025
Utility of pleural fluid-derived extracellular vesicles as a source of Mycobacterium tuberculosis antigens MPT51 and MPT64 for pleural TB diagnosis: a proof-of-concept study. doi:10.1016/j.tube.2024.102578 names it Tuberculosis (Edinb) 2025
Detection of MPT-64 protein in pleural tuberculosis cases by magnetic bead-gold nanoparticle-PCR amplified immunoassay. doi:10.1080/17460913.2024.2432179 Future Microbiol 2025
Impact of Mycobacterium tuberculosis H37Rv Infection on Extracellular Vesicle Cargo in Macrophages: Implications for Host-Pathogen Interaction. doi:10.3390/microorganisms12122405 Microorganisms 2024
The combination of Mycobacterium tuberculosis fusion proteins LT33 and LT28 induced strong protective immunity in mice. doi:10.3389/fimmu.2024.1450124 Front Immunol 2024
In silico analysis for the development of multi-epitope vaccines against Mycobacterium tuberculosis. doi:10.3389/fimmu.2024.1474346 Front Immunol 2024
PPE59 antibodies in tuberculous patients and potential use for diagnosis when assayed with other rapid biomarkers. doi:10.1590/0074-02760230183 Mem Inst Oswaldo Cruz 2024
Evaluation of mycobacterial microscopy and culture results from clinical samples: A five-year analysis. doi:10.5578/tt.202403955 Tuberk Toraks 2024
Rapid lateral flow test for Mycobacterium tuberculosis complex and non-tuberculous mycobacteria differentiation. doi:10.1007/s00253-024-13293-1 Appl Microbiol Biotechnol 2024
Comparing the cost-effectiveness of the MPT64-antigen detection test to Xpert MTB/RIF and ZN-microscopy for the diagnosis of Extrapulmonary Tuberculosis: An economic evaluation modelling study. doi:10.1371/journal.pgph.0003414 names it PLOS Glob Public Health 2024
Prevalence and predictors of NTM in presumed/confirmed drug-resistant TB. doi:10.5588/ijtldopen.24.0242 IJTLD Open 2024
Nanopore-based targeted next-generation sequencing of tissue samples for tuberculosis diagnosis. doi:10.3389/fmicb.2024.1403619 Front Microbiol 2024
Sustained transmission over two decades of a previously unrecognised MPT64 negative Mycobacterium tuberculosis strain in Queensland, Australia: a whole genome sequencing study. doi:10.1016/j.lanwpc.2024.101105 names it Lancet Reg Health West Pac 2024
Diagnostic Accuracy of the Abbott SD Bioline MPT64 antigen test for identification of MTB Complex in a U.S. Clinical Mycobacteriology Laboratory. doi:10.1016/j.heliyon.2024.e30501 names it Heliyon 2024
Diagnosis of Paediatric Extrapulmonary Tuberculosis by the MPT64 Antigen at a Tertiary Care Hospital. doi:10.7759/cureus.55688 names it Cureus 2024
Diagnosing adult and pediatric extrapulmonary tuberculosis by MPT64 antigen detection with immunohistochemistry and immunocytochemistry using reproduced polyclonal antibodies. doi:10.1002/2056-4538.12373 names it J Pathol Clin Res 2024
Ultrasensitive biosensing platform for Mycobacterium tuberculosis detection based on functionalized graphene devices. doi:10.3389/fbioe.2023.1313494 Front Bioeng Biotechnol 2023
Diagnosis of pleural tuberculosis by multi-targeted loop-mediated isothermal amplification assay based on SYBR Green I reaction: comparison with GeneXpert® MTB/RIF assay. doi:10.1080/17476348.2023.2292738 Expert Rev Respir Med 2023
Association of lineage 4.2.2 of Mycobacterium tuberculosis with the 63-bp deletion variant of the mpt64 gene. doi:10.1128/spectrum.01842-23 names it Microbiol Spectr 2023
Serological analysis reveals differential antibody responses between TB patients and latently infected individuals from the TB endemic country of Mozambique. doi:10.3389/fmed.2023.1286785 Front Med (Lausanne) 2023
Rapid diagnosis of TB using Aptamer-based assays for Mycobacterium tuberculosis antigens in children and adolescents. doi:10.4103/lungindia.lungindia_295_23 Lung India 2023
Xpert MTB/RIF Ultra on contaminated liquid cultures for tuberculosis and rifampicin-resistance detection: a diagnostic accuracy evaluation. doi:10.1016/S2666-5247(23)00169-6 Lancet Microbe 2023
Insight into the drug-resistant characteristics and genetic diversity of multidrug-resistant Mycobacterium tuberculosis in China. doi:10.1128/spectrum.01324-23 Microbiol Spectr 2023
High Positivity Rate of Urinary Mycobacterium tuberculosis Antigens Cocktail (ESAT-6, CFP-10, and MPT-64) in Active Tuberculosis Patients With and Without Human Immunodeficiency Virus Infection: A Cross-Sectional Study. doi:10.1177/2632010X231198831 Clin Pathol 2023
Rapid Identification of Nontuberculous Mycobacterium Species from Respiratory Specimens Using Nucleotide MALDI-TOF MS. doi:10.3390/microorganisms11081975 Microorganisms 2023
Quantification of mycobacterial proteins in extrapulmonary tuberculosis cases by nano-based real-time immuno-PCR. doi:10.2217/fmb-2023-0054 Future Microbiol 2023
Diagnosis of genitourinary tuberculosis: detection of mycobacterial lipoarabinomannan and MPT-64 biomarkers within urine extracellular vesicles by nano-based immuno-PCR assay. doi:10.1038/s41598-023-38740-3 Sci Rep 2023
Molecular Identification of Non-tuberculous Mycobacteria in Suspected Tuberculosis Cases in Central India. doi:10.7759/cureus.39992 Cureus 2023
MPT51 and MPT64-based antigen detection assay for the diagnosis of extrapulmonary tuberculosis from urine samples. doi:10.1016/j.diagmicrobio.2023.115973 names it Diagn Microbiol Infect Dis 2023
Synthesis of plant-based, self-adjuvanted, dual antigen specific to Mycobacterium tuberculosis as a novel tuberculosis subunit vaccine that elicits immunogenicity in rabbit. doi:10.1007/s10529-023-03371-1 Biotechnol Lett 2023
Aluminum Foil vs. Gold Film: Cost-Effective Substrate in Sandwich SERS Immunoassays of Biomarkers Reveals Potential for Selectivity Improvement. doi:10.3390/ijms24065578 Int J Mol Sci 2023
Detection of Mycobacterium tuberculosis Complex in Sputum Samples Using Droplet Digital PCR Targeting mpt64. doi:10.3390/pathogens12020345 names it Pathogens 2023
Novel Mutations in MPT64 Secretory Protein of Mycobacterium tuberculosis Complex. doi:10.3390/ijerph20032530 names it Int J Environ Res Public Health 2023
Non-amplification nucleic acid detection with thio-NAD cycling. doi:10.1016/j.mimet.2022.106647 J Microbiol Methods 2023
Improved diagnosis of extrapulmonary tuberculosis in adults with and without HIV in Mbeya, Tanzania using the MPT64 antigen detection test. doi:10.1371/journal.pgph.0001317 names it PLOS Glob Public Health 2022
Evaluation of Immunohistochemistry Technique for Diagnosis of Extrapulmonary Tuberculosis in Biopsy Tissue Specimen as Compared to Composite Diagnostic Criteria. doi:10.4103/jgid.jgid_112_22 J Glob Infect Dis 2022
Enhanced Serum IgG Detection Potential Using 38KD-MPT32-MPT64, CFP10-Mtb81-EspC Fusion Protein and Lipoarabinomannan (LAM) for Human Tuberculosis. doi:10.3390/pathogens11121545 names it Pathogens 2022
Listeria-vectored multi-antigenic tuberculosis vaccine protects C57BL/6 and BALB/c mice and guinea pigs against Mycobacterium tuberculosis challenge. doi:10.1038/s42003-022-04345-1 Commun Biol 2022
Expression and epitope prediction of MPT64 recombinant proteins from clinical isolates of Mycobacterium tuberculosis as immunoserodiagnostic candidates. doi:10.14202/vetworld.2022.2376-2383 names it Vet World 2022
Simultaneous Amperometric Aptasensor Based on Diazonium Grafted Screen-Printed Carbon Electrode for Detection of CFP10 and MPT64 Biomarkers for Early Tuberculosis Diagnosis. doi:10.3390/bios12110996 names it Biosensors (Basel) 2022
Mycobacterium tuberculosis exploits MPT64 to generate myeloid-derived suppressor cells to evade the immune system. doi:10.1007/s00018-022-04596-5 names it Cell Mol Life Sci 2022
Diagnosis of abdominal tuberculosis by multi-targeted (mpt64 and IS6110) loop-mediated isothermal amplification assay. doi:10.1111/jgh.16036 names it J Gastroenterol Hepatol 2022
Improving diagnosis of tuberculous lymphadenitis by combination of cytomorphology and MPT64 immunostaining on cell blocks from the fine needle aspirates. doi:10.1371/journal.pone.0276064 names it PLoS One 2022
Mycobacterium intracellulare among TB suspected patients in Bulgaria - microbiological aspects. doi:10.3897/folmed.64.e76901 Folia Med (Plovdiv) 2022
A Peptidomic Approach to Identify Novel Antigen Biomarkers for the Diagnosis of Tuberculosis. doi:10.2147/IDR.S373652 Infect Drug Resist 2022
Surface-Enhanced Carboxyphenyl Diazonium Functionalized Screen-Printed Carbon Electrode for the Screening of Tuberculosis in Sputum Samples. doi:10.3390/nano12152551 Nanomaterials (Basel) 2022
Aptasensor for Mycobacterium tuberculosis antigen MPT64 detection using anthraquinone derivative confined in ordered mesoporous carbon as a new redox nanoprobe. doi:10.1016/j.bioelechem.2022.108209 names it Bioelectrochemistry 2022
Diagnosis of genitourinary tuberculosis by loop-mediated isothermal amplification based on SYBR Green I dye reaction. doi:10.2144/btn-2022-0027 Biotechniques 2022
Doubled Nontuberculous Mycobacteria Isolation as a Consequence of Changes in the Diagnosis Algorithm. doi:10.2147/IDR.S368671 Infect Drug Resist 2022
Clinical presentations of nontuberculous mycobacteria as suspected and drug-resistant tuberculosis: Experience from a tertiary care center in Eastern India. doi:10.4103/ijmy.ijmy_68_22 Int J Mycobacteriol 2022
Identification of mycobacterial MPT-64 and ESAT-6 proteins in urogenital tuberculosis patients by real-time immuno-PCR. doi:10.2217/fmb-2022-0037 Future Microbiol 2022
Tuberculosis caused by Mycobacterium orygis in wild ungulates in Chennai, South India. doi:10.1111/tbed.14613 Transbound Emerg Dis 2022
Diagnosis of urogenital tuberculosis by multiplex-nested PCR targeting mpt64 (Rv1980c) and IS6110: comparison with multiplex PCR and GeneXpert® MTB/RIF. doi:10.1111/lam.13758 names it Lett Appl Microbiol 2022
Listeria-Vectored Multiantigenic Tuberculosis Vaccine Enhances Protective Immunity against Aerosol Challenge with Virulent Mycobacterium tuberculosis in BCG-Immunized C57BL/6 and BALB/c Mice. doi:10.1128/mbio.00687-22 mBio 2022
Reliability of MPT64 rapid test in identifying Mycobacterium tuberculosis complex. doi:10.1016/j.ijmmb.2022.05.003 names it Indian J Med Microbiol 2022
Molecular characterization of Mycobacterium tuberculosis through MPT64 gene polymorphism using next-generation sequencing technology. doi:10.2217/fmb-2020-0231 names it Future Microbiol 2022
Biorecognition and detection of antigens from Mycobacterium tuberculosis using a sandwich ELISA associated with magnetic nanoparticles. doi:10.1016/j.jpba.2022.114749 J Pharm Biomed Anal 2022
Susceptibility pattern of Mycobacterium tuberculosis over a period of five years at Indus Hospital and Health Network, Karachi, Pakistan. doi:10.12669/pjms.38.ICON-2022.5778 Pak J Med Sci 2022
From NTM (Nontuberculous mycobacterium) to Gordonia bronchialis-A Diagnostic Challenge in the COPD Patient. doi:10.3390/diagnostics12020307 Diagnostics (Basel) 2022
Concurrent evaluation of cytokines improves the accuracy of antibodies against Mycobacterium tuberculosis antigens in the diagnosis of active tuberculosis. doi:10.1016/j.tube.2022.102169 Tuberculosis (Edinb) 2022
Bacteriological and molecular characterization of Mycobacterium bovis isolates from tuberculous lesions collected among slaughtered cattle, Northwest Ethiopia. doi:10.1186/s12866-021-02349-1 BMC Microbiol 2021
Aptasensor for the Detection of Mycobacterium tuberculosis in Sputum Utilising CFP10-ESAT6 Protein as a Selective Biomarker. doi:10.3390/nano11092446 Nanomaterials (Basel) 2021
MPT64 antigen detection test improves diagnosis of pediatric extrapulmonary tuberculosis in Mbeya, Tanzania. doi:10.1038/s41598-021-97010-2 names it Sci Rep 2021
Immunochemistry-Based Diagnosis of Extrapulmonary Tuberculosis: A Strategy for Large-Scale Production of MPT64-Antibodies for Use in the MPT64 Antigen Detection Test. doi:10.3390/antib10030034 names it Antibodies (Basel) 2021
Diagnosis of osteoarticular tuberculosis: multi-targeted loop-mediated isothermal amplification assay versus multiplex PCR. doi:10.2217/fmb-2021-0030 Future Microbiol 2021
Novel phage display-derived recombinant antibodies recognizing both MPT64 native and mutant (63-bp deletion) are promising tools for tuberculosis diagnosis. doi:10.1016/j.biologicals.2021.07.002 names it Biologicals 2021
Comparison of simple and rapid extracting methods of free-tags Mycobacterium tuberculosis protein 64 Recombinant Protein from polyacrylamide gel: Electroelution and the optimized passive elution. doi:10.4103/japtr.JAPTR_318_20 J Adv Pharm Technol Res 2021
Multi-Functional MPT Protein as a Therapeutic Agent against Mycobacterium tuberculosis. doi:10.3390/biomedicines9050545 Biomedicines 2021
Label-Free Comparative Proteomics of Differentially Expressed Mycobacterium tuberculosis Protein in Rifampicin-Related Drug-Resistant Strains. doi:10.3390/pathogens10050607 Pathogens 2021
Application value of tissue tuberculosis antigen combined with Xpert MTB/RIF detection in differential diagnoses of intestinal tuberculosis and Crohn's disease. doi:10.1186/s12879-021-06210-8 BMC Infect Dis 2021
Performance assessment of SD Bioline TB MPT64 assay for the diagnosis of Mycobacterium tuberculosis complex in Lagos, Nigeria. doi:10.1080/15321819.2021.1911812 names it J Immunoassay Immunochem 2021
MPT64 assays for the rapid detection of Mycobacterium tuberculosis. doi:10.1186/s12879-021-06022-w names it BMC Infect Dis 2021
Prevalence and speciation of non-tuberculous mycobacteria among pulmonary and extrapulmonary tuberculosis suspects in South India. doi:10.1016/j.jiph.2020.12.027 J Infect Public Health 2021
Cutaneous Coinfection of Cytomegalovirus and Mycobacterium chelonae Accelerated by Immunosuppression. doi:10.1155/2021/8819560 Case Rep Pathol 2021
Id3 and Bcl6 Promote the Development of Long-Term Immune Memory Induced by Tuberculosis Subunit Vaccine. doi:10.3390/vaccines9020126 Vaccines (Basel) 2021
Diagnostic Utility of Biplex/Multiplex Polymerase Chain Reaction in Infectious Granulomatous Dermatitis in North Indian Population. doi:10.1097/DAD.0000000000001878 Am J Dermatopathol 2021
Genetic diversity of the Mycobacterium tuberculosis complex strains from newly diagnosed tuberculosis patients in Northwest Ethiopia reveals a predominance of East-African-Indian and Euro-American lineages. doi:10.1016/j.ijid.2020.11.129 Int J Infect Dis 2021
The overview and perspectives of biosensors and Mycobacterium tuberculosis: A systematic review. doi:10.1002/jcp.30007 J Cell Physiol 2021
Mucosal Therapy of Multi-Drug Resistant Tuberculosis With IgA and Interferon-γ. doi:10.3389/fimmu.2020.582833 Front Immunol 2020
Diagnosis of tuberculosis by nanoparticle-based immuno-PCR assay based on mycobacterial MPT64 and CFP-10 detection. doi:10.2217/nnm-2020-0258 names it Nanomedicine (Lond) 2020
Evaluation of factors influencing Mycobacterium tuberculosis complex recovery and contamination rates in MGIT960. doi:10.1016/j.ijtb.2020.07.016 Indian J Tuberc 2020
A novel, rapid (within hours) culture-free diagnostic method for detecting live Mycobacterium tuberculosis with high sensitivity. doi:10.1016/j.ebiom.2020.103007 EBioMedicine 2020
Emergence of nontuberculous mycobacteria infections during bedaquiline-containing regimens in multidrug-resistant tuberculosis patients. doi:10.1016/j.ijid.2020.08.080 Int J Infect Dis 2020
Carbon nanotube-based thin-film resistive sensor for point-of-care screening of tuberculosis. doi:10.1007/s10544-020-00506-3 Biomed Microdevices 2020
Mycobacterial antigens in pleural fluid mononuclear cells to diagnose pleural tuberculosis in HIV co-infected patients. doi:10.1186/s12879-020-05165-6 BMC Infect Dis 2020
Mycobacterium smegmatis Vaccine Vector Elicits CD4+ Th17 and CD8+ Tc17 T Cells With Therapeutic Potential to Infections With Mycobacterium avium. doi:10.3389/fimmu.2020.01116 Front Immunol 2020
Screening and evaluation of Mycobacterium tuberculosis diagnostic antigens. doi:10.1007/s10096-020-03951-3 Eur J Clin Microbiol Infect Dis 2020
BCG Infection due to MPT64-Negative Strain: A Diagnostic Challenge. doi:10.4269/ajtmh.19-0853 names it Am J Trop Med Hyg 2020
Evaluation of multi-antigen serological screening for active tuberculosis among people living with HIV. doi:10.1371/journal.pone.0234130 PLoS One 2020
Ultrasensitive enzyme-linked immunosorbent assay for the detection of MPT64 secretory antigen to evaluate Mycobacterium tuberculosis viability in sputum. doi:10.1016/j.ijid.2020.04.059 names it Int J Infect Dis 2020
Whole genome enrichment approach for rapid detection of Mycobacterium tuberculosis and drug resistance-associated mutations from direct sputum sequencing. doi:10.1016/j.tube.2020.101915 Tuberculosis (Edinb) 2020
Diagnosis of extrapulmonary tuberculosis using the MPT64 antigen detection test in a high-income low tuberculosis prevalence setting. doi:10.1186/s12879-020-4852-z names it BMC Infect Dis 2020
Revised guidelines for Australian laboratories performing mycobacteriology testing. doi:10.33321/cdi.2020.44.2 Commun Dis Intell (2018) 2020
Evaluation of Various Diagnostic Techniques for the Diagnosis of Pulmonary and Extra Pulmonary Tuberculosis at a Tertiary Care Center in North India. doi:10.2174/1871526519666191011165702 Infect Disord Drug Targets 2020
Optimization of culture conditions for Mpt64 synthetic gene expression in Escherichia coli BL21 (DE3) using surface response methodology. doi:10.1016/j.heliyon.2019.e02741 names it Heliyon 2019
Mutation in MPT64 gene influencing diagnostic accuracy of SD Bioline assay (capilia). doi:10.1186/s12879-019-4671-2 names it BMC Infect Dis 2019
Polymorphism of MPT64 and PstS1 in Mycobacterium tuberculosis is not likely to affect relative immune reaction in human. doi:10.1097/MD.0000000000018073 names it Medicine (Baltimore) 2019
An aptasensor for the detection of Mycobacterium tuberculosis secreted immunogenic protein MPT64 in clinical samples towards tuberculosis detection. doi:10.1038/s41598-019-52685-6 names it Sci Rep 2019
IL-2 Restores T-Cell Dysfunction Induced by Persistent Mycobacterium tuberculosis Antigen Stimulation. doi:10.3389/fimmu.2019.02350 Front Immunol 2019
IgA and IgG antibody detection of mycobacterial antigens in pleural fluid and serum from pleural tuberculous patients. doi:10.1186/s12865-019-0315-y BMC Immunol 2019
A sandwich-type electrochemical aptasensor for Mycobacterium tuberculosis MPT64 antigen detection using C(60)NPs decorated N-CNTs/GO nanocomposite coupled with conductive PEI-functionalized metal-organic framework. doi:10.1016/j.biomaterials.2019.119253 names it Biomaterials 2019
Screening Mycobacterium tuberculosis Secreted Proteins Identifies Mpt64 as a Eukaryotic Membrane-Binding Bacterial Effector. doi:10.1128/mSphere.00354-19 names it mSphere 2019
Quantitative detection of a cocktail of mycobacterial MPT64 and PstS1 in tuberculosis patients by real-time immuno-PCR. doi:10.2217/fmb-2018-0284 names it Future Microbiol 2019
A loop-mediated isothermal amplification assay for the diagnosis of pulmonary tuberculosis. doi:10.1111/lam.13115 Lett Appl Microbiol 2019
Anaphylatoxins Enhance Recruitment of Nonclassical Monocytes via Chemokines Produced by Pleural Mesothelial Cells in Tuberculous Pleural Effusion. doi:10.1165/rcmb.2018-0075OC Am J Respir Cell Mol Biol 2019
Loop-Mediated Isothermal Amplification for Rapid Identification of Mycobacterium tuberculosis in Comparison with Immunochromatographic SD Bioline MPT64 Rapid(®) in a High Burden Setting. doi:10.7883/yoken.JJID.2018.128 names it Jpn J Infect Dis 2019
Colorimetric Detection of MPT64 Antibody Based on an Aptamer Adsorbed Magnetic Nanoparticles for Diagnosis of Tuberculosis. doi:10.1166/jnn.2019.15905 names it J Nanosci Nanotechnol 2019
Electrochemical aptasensor using optimized surface chemistry for the detection of Mycobacterium tuberculosis secreted protein MPT64 in human serum. doi:10.1016/j.bios.2018.07.053 names it Biosens Bioelectron 2019
Designing and Construction of a Cloning Vector Containing mpt64 Gene of Mycobacterium tuberculosis. names it Tanaffos 2018
Dual-aptamer-based voltammetric biosensor for the Mycobacterium tuberculosis antigen MPT64 by using a gold electrode modified with a peroxidase loaded composite consisting of gold nanoparticles and a Zr(IV)/terephthalate metal-organic framework. doi:10.1007/s00604-018-3081-2 names it Mikrochim Acta 2018
Low sensitivity of the MPT64 identification test to detect lineage 5 of the Mycobacterium tuberculosis complex. doi:10.1099/jmm.0.000846 names it J Med Microbiol 2018
Voltammetric immunoassay for Mycobacterium tuberculosis secretory protein MPT64 based on a synergistic amplification strategy using rolling circle amplification and a gold electrode modified with graphene oxide, Fe(3)O(4) and Pt nanoparticles. doi:10.1007/s00604-018-2972-6 names it Mikrochim Acta 2018
Production of MPT-64 recombinant protein from virulent strain of Mycobacterium bovis. Iran J Vet Res 2018
Evaluation of panels of Mycobacterium tuberculosis antigens for serodiagnosis of tuberculosis. doi:10.5588/ijtld.18.0060 Int J Tuberc Lung Dis 2018
MPT64 patch test for the diagnosis of active pulmonary tuberculosis: a randomised controlled trial in Peru. doi:10.5588/ijtld.17.0716 names it Int J Tuberc Lung Dis 2018
Rapid screening drug susceptibility test in tuberculosis using sandwich electrochemical immunosensor. doi:10.1016/j.aca.2018.04.064 Anal Chim Acta 2018
Prolonged intervals during Mycobacterium tuberculosis subunit vaccine boosting contributes to eliciting immunity mediated by central memory-like T cells. doi:10.1016/j.tube.2018.04.006 Tuberculosis (Edinb) 2018
MPT64 antigen detection test improves routine diagnosis of extrapulmonary tuberculosis in a low-resource setting: A study from the tertiary care hospital in Zanzibar. doi:10.1371/journal.pone.0196723 names it PLoS One 2018
HIV-negative pulmonary disease caused by nontuberculous mycobacteria in Southern Brazil: clinical and microbiological characterization. doi:10.21037/jtd.2018.03.66 J Thorac Dis 2018
Growth characteristics of liquid cultures increase the reliability of presumptive identification of Mycobacterium tuberculosis complex. doi:10.1099/jmm.0.000734 J Med Microbiol 2018
Use of an immunochromatographic assay for rapid identification of Mycobacterium tuberculosis complex clinical isolates in routine diagnosis. doi:10.1099/jmm.0.000726 J Med Microbiol 2018
Comparative evaluation of GeneXpert MTB/RIF and multiplex PCR targeting mpb64 and IS6110 for the diagnosis of pleural TB. doi:10.2217/fmb-2017-0147 Future Microbiol 2018
Higher-than-expected prevalence of non-tuberculous mycobacteria in HIV setting in Botswana: Implications for diagnostic algorithms using Xpert MTB/RIF assay. doi:10.1371/journal.pone.0189981 PLoS One 2017
Tuberculosis among Jimma University Undergraduate Students: First Insight about the Burden of Tuberculosis in Ethiopia Universities-Cross-Sectional Study. doi:10.1155/2017/9840670 Int J Bacteriol 2017
Comparison of the Performance of Urinary Mycobacterium tuberculosis Antigens Cocktail (ESAT6, CFP10, and MPT64) with Culture and Microscopy in Pulmonary Tuberculosis Patients. doi:10.1155/2017/3259329 names it Int J Microbiol 2017
CFD Modeling of Chamber Filling in a Micro-Biosensor for Protein Detection. doi:10.3390/bios7040045 Biosensors (Basel) 2017
Identification of TBc: Using MTP 64 protein and cord formation. J Pak Med Assoc 2017
Evaluation of the SD Bioline TB Ag MPT64 test for identification of Mycobacterium tuberculosis complex from liquid cultures in Southwestern Uganda. doi:10.4102/ajlm.v6i2.383 names it Afr J Lab Med 2017
Potential of High-Affinity, Slow Off-Rate Modified Aptamer Reagents for Mycobacterium tuberculosis Proteins as Tools for Infection Models and Diagnostic Applications. doi:10.1128/JCM.00469-17 J Clin Microbiol 2017
Evaluation of a new rapid kit, BD MGIT TBc identification test for confirmation of Mycobacterium tuberculosis complex. doi:10.4103/IJPM.IJPM_695_15 Indian J Pathol Microbiol 2017
Second generation multiple reaction monitoring assays for enhanced detection of ultra-low abundance Mycobacterium tuberculosis peptides in human serum. doi:10.1186/s12014-017-9156-y Clin Proteomics 2017
A New Rabbit-Skin Model to Evaluate Protective Efficacy of Tuberculosis Vaccines. doi:10.3389/fmicb.2017.00842 Front Microbiol 2017
Electrochemical determination of M. tuberculosis antigen based on Poly(3,4-ethylenedioxythiophene) and functionalized carbon nanotubes hybrid platform. doi:10.1016/j.talanta.2017.04.063 Talanta 2017
MPT64 gene mutations leading to non-reactivity on a rapid immunochromatographic assay. doi:10.3855/jidc.8768 names it J Infect Dev Ctries 2017
Selection, characterization, and application of DNA aptamers for detection of Mycobacterium tuberculosis secreted protein MPT64. doi:10.1016/j.tube.2017.03.004 names it Tuberculosis (Edinb) 2017
Genetic diversity of immune-related antigens in Region of Difference 2 of Mycobacterium tuberculosis strains. doi:10.1016/j.tube.2016.05.002 Tuberculosis (Edinb) 2017
Subunit Vaccines Consisting of Antigens from Dormant and Replicating Bacteria Show Promising Therapeutic Effect against Mycobacterium Bovis BCG Latent Infection. doi:10.1111/sji.12556 Scand J Immunol 2017
Detection of a combination of serum IgG and IgA antibodies against selected mycobacterial targets provides promising diagnostic signatures for active TB. doi:10.18632/oncotarget.16401 Oncotarget 2017
Fullerene-doped polyaniline as new redox nanoprobe and catalyst in electrochemical aptasensor for ultrasensitive detection of Mycobacterium tuberculosis MPT64 antigen in human serum. doi:10.1016/j.biomaterials.2017.04.010 names it Biomaterials 2017
Secretory Proteome Analysis of Streptomycin-Resistant Mycobacterium tuberculosis Clinical Isolates. doi:10.1177/2472555217698428 SLAS Discov 2017
Rapid and Specific Diagnosis of Extrapulmonary Tuberculosis by Immunostaining of Tissues and Aspirates With Anti-MPT64. doi:10.1097/PAI.0000000000000300 names it Appl Immunohistochem Mol Morphol 2017
The First population structure and comparative genomics analysis of Mycobacterium africanum strains from Ghana reveals higher diversity of Lineage 5. doi:10.1016/j.ijmyco.2016.09.051 Int J Mycobacteriol 2016
Cloning, expression, and purification of recombinant protein MPT-64 from a virulent strain of Mycobacterium bovis in a prokaryotic system. doi:10.1016/j.ijmyco.2016.10.027 Int J Mycobacteriol 2016
Rapid detection of Mycobacterium tuberculosis complex in sputum Samples using PURE TB-LAMP assay. doi:10.1016/j.ijmyco.2016.09.025 Int J Mycobacteriol 2016
Prevalence and species spectrum of both pulmonary and extrapulmonary nontuberculous mycobacteria isolates at a tertiary care center. doi:10.1016/j.ijmyco.2016.06.008 Int J Mycobacteriol 2016
NTM Pulmonary Infection: Differential Diagnosis of MDR TB Pulmonary Infection. J Assoc Physicians India 2016
Performance of an in-house real-time polymerase chain reaction for identification of Mycobacterium tuberculosis isolates in laboratory routine diagnosis from a high burden setting. doi:10.1590/0074-02760160048 Mem Inst Oswaldo Cruz 2016
Comparison of MALDI-TOF MS, nucleic acid hybridization and the MPT64 immunochromatographic test for the identification of M. tuberculosis and non-tuberculosis Mycobacterium species. names it New Microbiol 2016
Impact of the Mycobaterium africanum West Africa 2 Lineage on TB Diagnostics in West Africa: Decreased Sensitivity of Rapid Identification Tests in The Gambia. doi:10.1371/journal.pntd.0004801 PLoS Negl Trop Dis 2016
Genotyping of mutations detected with GeneXpert. doi:10.1016/j.ijmyco.2016.01.001 Int J Mycobacteriol 2016
Utility of MPT64 antigen test for differentiating mycobacteria: Can correlation with liquid culture smear morphology add further value? doi:10.4103/0377-4929.182009 names it Indian J Pathol Microbiol 2016
Design and construction of a DNA origami drug delivery system based on MPT64 antibody aptamer for tuberculosis treatment. doi:10.19082/1857 names it Electron Physician 2016
A multistage mycobacterium tuberculosis subunit vaccine LT70 including latency antigen Rv2626c induces long-term protection against tuberculosis. doi:10.1080/21645515.2016.1141159 Hum Vaccin Immunother 2016
A novel liposome adjuvant DPC mediates Mycobacterium tuberculosis subunit vaccine well to induce cell-mediated immunity and high protective efficacy in mice. doi:10.1016/j.vaccine.2016.01.049 Vaccine 2016
Unusual cause of chest pain: empyema necessitans and tubercular osteomyelitis of the rib in an immunocompetent man. doi:10.1136/bcr-2015-212311 BMJ Case Rep 2016
Utility of a lateral flow assay for culture confirmation of Mycobacterium tuberculosis complex. doi:10.1016/j.mjafi.2014.12.021 Med J Armed Forces India 2016
IL-28B down-regulates regulatory T cells but does not improve the protective immunity following tuberculosis subunit vaccine immunization. doi:10.1093/intimm/dxv061 Int Immunol 2016
Rapid detection of Mycobacterium tuberculosis complex by real-time PCR in sputum samples and its use in the routine diagnosis in a reference laboratory. doi:10.1099/jmm.0.000121 J Med Microbiol 2015
False-negative BD MGIT™ TBc Identification Test results in routine tuberculosis diagnosis: a New Zealand perspective. doi:10.5588/ijtld.15.0032 Int J Tuberc Lung Dis 2015
Rapid identification of Mycobacterium tuberculosis complex in clinical isolates by combining presumptive cord formation and MPT64 Antigen Immunochromatographic Assay. doi:10.1016/j.ijtb.2015.04.007 names it Indian J Tuberc 2015
Multi-Stage Tuberculosis Subunit Vaccine Candidate LT69 Provides High Protection against Mycobacterium tuberculosis Infection in Mice. doi:10.1371/journal.pone.0130641 PLoS One 2015
Utility of MPT64 Antigen Detection for Rapid Confirmation of Mycobacterium tuberculosis Complex. doi:10.4103/0974-777X.154443 names it J Glob Infect Dis 2015
Impact of 63-bp deletion and single-base mutation in mpt64 gene on M.tb diagnosis. names it Int J Clin Exp Pathol 2015
High level of IFN-γ released from whole blood of human tuberculosis infections following stimulation with Rv2073c of Mycobacterium tuberculosis. doi:10.1016/j.mimet.2015.05.007 J Microbiol Methods 2015
Prevalence of nontuberculous mycobacteria among extrapulmonary tuberculosis cases in tertiary care centers in Northern India. doi:10.1155/2015/465403 Biomed Res Int 2015
Association of Mycobacterium tuberculosis in the causation of Eales' disease: an institutional experience. doi:10.4103/0255-0857.148829 Indian J Med Microbiol 2015
The viability and protein expression of Beijing/W lineage Mycobacterium tuberculosis circulating in Xinjiang, China. doi:10.1007/s00284-015-0776-z Curr Microbiol 2015
Single nucleotide polymorphism in Ag85 genes of Mycobacterium tuberculosis complex: analysis of 178 clinical isolates from China and 13 BCG strains. doi:10.7150/ijms.9951 Int J Med Sci 2015
Evaluating the Auto-MODS assay, a novel tool for tuberculosis diagnosis for use in resource-limited settings. doi:10.1128/JCM.01946-14 J Clin Microbiol 2015
Performance of the SD Bioline TB Ag MPT64 Rapid test for quick confirmation of Mycobacterium bovis isolates from animals. doi:10.4142/jvs.2015.16.1.31 names it J Vet Sci 2015
[Evaluation of the BD MGITTM technique for identifying the Mycobacterium tuberculosis complex]. Rev Salud Publica (Bogota) 2014
Assessing humoral immune response of 4 recombinant antigens for serodiagnosis of tuberculosis. doi:10.1016/j.tube.2014.09.006 Tuberculosis (Edinb) 2014
Immunocytochemical detection of Mycobacterium Tuberculosis complex specific antigen, MPT64, improves diagnosis of tuberculous lymphadenitis and tuberculous pleuritis. doi:10.1186/s12879-014-0585-1 names it BMC Infect Dis 2014
Differential in vivo expression of mycobacterial antigens in Mycobacterium tuberculosis infected lungs and lymph node tissues. doi:10.1186/1471-2334-14-535 BMC Infect Dis 2014
MPT64 polymorphisms of Mycobacterium tuberculosis strains suggest ongoing immune evasion. doi:10.1016/j.tube.2014.08.013 names it Tuberculosis (Edinb) 2014
Detection of Mycobacterium tuberculosis peptides in the exosomes of patients with active and latent M. tuberculosis infection using MRM-MS. doi:10.1371/journal.pone.0103811 PLoS One 2014
MPT64 protein from Mycobacterium tuberculosis inhibits apoptosis of macrophages through NF-kB-miRNA21-Bcl-2 pathway. doi:10.1371/journal.pone.0100949 names it PLoS One 2014
Recombinant Bacillus subtilis spores expressing MPT64 evaluated as a vaccine against tuberculosis in the murine model. doi:10.1111/1574-6968.12525 names it FEMS Microbiol Lett 2014
Evaluation of an immunochromatographic test kit for detecting Mycobacterium tuberculosis complex in sputum samples and on solid and in liquid cultures. Southeast Asian J Trop Med Public Health 2014
Rapid Immunochromatographic Test for the Identification and Discrimination of Mycobacterium tuberculosis Complex Isolates from Non-tuberculous Mycobacteria. doi:10.7860/JCDR/2014/7098.4253 J Clin Diagn Res 2014
IgG, IgM and IgA antibodies against the novel polyprotein in active tuberculosis. doi:10.1186/1471-2334-14-336 BMC Infect Dis 2014
Homologous prime boosting based on intranasal delivery of non-pathogenic invasive Escherichia coli expressing MPT64, decreases Mycobacterium tuberculosis dissemination. doi:10.1016/j.vaccine.2014.05.060 names it Vaccine 2014
Development of a quantitative sandwich enzyme-linked immunosorbent assay for detecting the MPT64 antigen of Mycobacterium tuberculosis. doi:10.3349/ymj.2014.55.3.746 names it Yonsei Med J 2014
Dynamic evolution and immunoreactivity of aptamers binding to polyclonal antibodies against MPT64 antigen of Mycobacterium tuberculosis. doi:10.1007/s10096-014-2056-4 names it Eur J Clin Microbiol Infect Dis 2014
Utility of B-cell epitopes based peptides of RD1 and RD2 antigens for immunodiagnosis of pulmonary tuberculosis. doi:10.1016/j.diagmicrobio.2013.12.018 Diagn Microbiol Infect Dis 2014
Comparative evaluation of three immunochromatographic identification tests for culture confirmation of Mycobacterium tuberculosis complex. doi:10.1186/1471-2334-14-54 BMC Infect Dis 2014
Role of GenoType(®) Mycobacterium Common Mycobacteria/Additional Species Assay for Rapid Differentiation Between Mycobacterium tuberculosis Complex and Different Species of Non-Tuberculous Mycobacteria. doi:10.4103/0974-2727.119847 J Lab Physicians 2013
Mycobacterium tuberculosis MPT64 stimulates the activation of murine macrophage modulated by IFN-γ. names it Eur Rev Med Pharmacol Sci 2013
Drug Resistance Pattern of MTB Isolates from PTB Patients. doi:10.1155/2013/862530 Tuberc Res Treat 2013
Heat fixed but unstained slide smears are infectious to laboratory staff. Indian J Tuberc 2013
Commercial MPT64-based tests for rapid identification of Mycobacterium tuberculosis complex: a meta-analysis. doi:10.1016/j.jinf.2013.06.009 names it J Infect 2013
Mycobacterium tuberculosis infection is associated with the development of erythema nodosum and nodular vasculitis. doi:10.1371/journal.pone.0062653 PLoS One 2013
Tuberculosis diagnosis using immunodominant, secreted antigens of Mycobacterium tuberculosis. doi:10.1016/j.tube.2013.03.003 Tuberculosis (Edinb) 2013
Polymorphism of antigen MPT64 in Mycobacterium tuberculosis strains. doi:10.1128/JCM.02955-12 names it J Clin Microbiol 2013
Enhanced serodiagnostic utility of novel Mycobacterium tuberculosis polyproteins. doi:10.1016/j.jinf.2012.10.029 J Infect 2013
Use of recombinant purified protein derivative (PPD) antigens as specific skin test for tuberculosis. Indian J Med Res 2012
Evaluation of (SD) MPT64 antigen rapid test, for fast and accurate identification of Mycobacterium tuberculosis complex. doi:10.1097/PAT.0b013e328359d565 names it Pathology 2012
Comparison of the MGIT TBc immunochromatographic assay with the Accuprobe Gen-Probe TB assay for identification of Mycobacterium tuberculosis complex: results from a low-burden tuberculosis setting. doi:10.1016/j.diagmicrobio.2012.08.007 Diagn Microbiol Infect Dis 2012
Construction of a DNA vaccine based on the Mycobacterium tuberculosis Ag85A/MPT64 fusion gene and evaluation of its immunogenicity. doi:10.3892/mmr.2012.1109 names it Mol Med Rep 2012
Evaluation of in-house mpt64 real-time PCR for rapid detection of Mycobacterium tuberculosis in pulmonary and extra-pulmonary specimens. doi:10.1016/j.bjid.2012.08.010 names it Braz J Infect Dis 2012
Immunochromatographic assays for detection of Mycobacterium tuberculosis: what is the perfect time to test? doi:10.1016/j.diagmicrobio.2012.06.018 Diagn Microbiol Infect Dis 2012
Utility of MPT 64 antigen detection assay for rapid characterization of mycobacteria in a resource constrained setting. Indian J Tuberc 2012
Evaluation of an immunochromatographic test for discrimination between Mycobacterium tuberculosis complex & non tuberculous mycobacteria in clinical isolates from extra-pulmonary tuberculosis. Indian J Med Res 2012
Clinical value of ELISA-MPT64 for the diagnosis of tuberculous pleurisy. doi:10.1007/s00284-012-0157-9 names it Curr Microbiol 2012
Evaluation of the clinical value of ELISA based on MPT64 antibody aptamer for serological diagnosis of pulmonary tuberculosis. doi:10.1186/1471-2334-12-96 names it BMC Infect Dis 2012
A novel tuberculosis DNA vaccine in an HIV-1 p24 protein backbone confers protection against Mycobacterium tuberculosis and simultaneously elicits robust humoral and cellular responses to HIV-1. doi:10.1128/CVI.05700-11 Clin Vaccine Immunol 2012
Prime-boost vaccination with rBCG/rAd35 enhances CD8⁺ cytolytic T-cell responses in lesions from Mycobacterium tuberculosis-infected primates. doi:10.2119/molmed.2011.00222 Mol Med 2012
Subunit vaccine candidate AMM down-regulated the regulatory T cells and enhanced the protective immunity of BCG on a suitable schedule. doi:10.1111/j.1365-3083.2011.02666.x Scand J Immunol 2012
Immunogenicity and protective efficacy of the Mycobacterium avium subsp. paratuberculosis attenuated mutants against challenge in a mouse model. doi:10.1016/j.vaccine.2011.11.029 Vaccine 2012
Improved cellular immune response elicited by a ubiquitin-fused DNA vaccine against Mycobacterium tuberculosis. doi:10.1089/dna.2011.1309 DNA Cell Biol 2012
Rapid diagnosis of tuberculosis in aspirate, effusions, and cerebrospinal fluid by immunocytochemical detection of Mycobacterium tuberculosis complex specific antigen MPT64. doi:10.1002/dc.21637 names it Diagn Cytopathol 2012
Serum antibody responses to 10 Mycobacterium tuberculosis proteins, purified protein derivative, and old tuberculin in natural and experimental tuberculosis in rhesus monkeys. doi:10.1128/CVI.05329-11 Clin Vaccine Immunol 2011
Validation of an immunochromatographic assay kit for the identification of the Mycobacterium tuberculosis complex. doi:10.1590/s0074-02762011000600022 Mem Inst Oswaldo Cruz 2011
Evaluation of a rapid assay for identification of Mycobacterium tuberculosis grown in solid and liquid media. doi:10.5588/ijtld.10.0709 Int J Tuberc Lung Dis 2011
Performance of the MGIT TBc identification test and meta-analysis of MPT64 assays for identification of the Mycobacterium tuberculosis complex in liquid culture. doi:10.1128/JCM.05995-11 names it J Clin Microbiol 2011
Cloning, protein expression and display of synthetic multi-epitope mycobacterial antigens on Salmonella typhi Ty21a cell surface. Indian J Exp Biol 2011
Evaluation of a novel fusion protein antigen for rapid serodiagnosis of tuberculosis. doi:10.1002/jcla.20483 J Clin Lab Anal 2011
PPE_MPTR genes are differentially expressed by Mycobacterium tuberculosis in vivo. doi:10.1016/j.tube.2011.08.002 Tuberculosis (Edinb) 2011
Mycobacterial infection after intravesical bacillus Calmette-Guërin treatment for bladder cancer: a case report. doi:10.3343/kjlm.2011.31.3.197 Korean J Lab Med 2011
Evaluation of the TB Ag MPT64 Rapid test for the identification of Mycobacterium tuberculosis complex. doi:10.5588/ijtld.10.0474 names it Int J Tuberc Lung Dis 2011
Expression, purification, and characterization of protective MPT64 antigen protein and identification of its multimers isolated from nontoxic Mycobacterium tuberculosis H37Ra. doi:10.1002/bab.26 names it Biotechnol Appl Biochem 2011
[Isolation rate of Mycobacterium tuberculosis complex from patients with suspected tuberculosis and identification of the strains with BACTEC™ NAP and immunochromatographic TB Ag MPT64 Rapid™ Tests]. names it Mikrobiyol Bul 2011
MPT 64 Antigen detection for Rapid confirmation of M.tuberculosis isolates. doi:10.1186/1756-0500-4-79 BMC Res Notes 2011
Assessment of the SD Bioline Ag MPT64 Rapid™ and the MGIT™ TBc identification tests for the diagnosis of tuberculosis. doi:10.1016/j.diagmicrobio.2010.12.011 names it Diagn Microbiol Infect Dis 2011
Evaluation of an immunochromatographic assay for rapid identification of Mycobacterium tuberculosis complex in clinical isolates. doi:10.1016/j.diagmicrobio.2010.11.009 Diagn Microbiol Infect Dis 2011
A DNA vaccine expressing CFP21 and MPT64 fusion protein enhances BCG-induced protective immunity against Mycobacterium tuberculosis infection in mice. doi:10.1007/s00430-011-0188-z names it Med Microbiol Immunol 2011
Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice. doi:10.1111/j.1365-3083.2011.02531.x Scand J Immunol 2011
[Evaluation of the SD BIOLINE TB Ag MPT64 Rapid® for the diagnosis of tuberculosis]. doi:10.1016/j.patbio.2010.08.007 names it Pathol Biol (Paris) 2011
Evaluation of the BD MGIT TBc Identification Test (TBc ID), a rapid chromatographic immunoassay for the detection of Mycobacterium tuberculosis complex from liquid culture. doi:10.1016/j.mimet.2010.12.003 J Microbiol Methods 2011
Cloning of guinea pig IL-4: reduced IL-4 mRNA after vaccination or Mycobacterium tuberculosis infection. doi:10.1016/j.tube.2010.11.006 Tuberculosis (Edinb) 2011
Region of difference 2 contributes to virulence of Mycobacterium tuberculosis. doi:10.1128/IAI.00824-10 Infect Immun 2011
Selection and application of peptide mimotopes of MPT64 protein in Mycobacterium tuberculosis. doi:10.1099/jmm.0.025098-0 names it J Med Microbiol 2011
[Rapid identification of Mycobacterium tuberculosis complex from broth cultures by immunochromatographic assay]. Rev Esp Quimioter 2010
Assessment of the IgA immunoassay diagnostic potential of the Mycobacterium tuberculosis MT10.3-MPT64 fusion protein in tuberculous pleural fluid. doi:10.1128/CVI.00372-10 names it Clin Vaccine Immunol 2010
Surface expression of MPT64 as a fusion with the PE domain of PE_PGRS33 enhances Mycobacterium bovis BCG protective activity against Mycobacterium tuberculosis in mice. doi:10.1128/IAI.00267-10 names it Infect Immun 2010
Oral delivery of a DNA vaccine against tuberculosis using operator-repressor titration in a Salmonella enterica vector. doi:10.1016/j.vaccine.2010.09.001 Vaccine 2010
Evaluation of Lionex TB kits and mycobacterial antigens for IgG and IgA detection in cerebrospinal fluid from tuberculosis meningitis patients. doi:10.1590/s0074-02762010000500022 Mem Inst Oswaldo Cruz 2010
In silico binding predictions for identification of HLA-DR-promiscuous regions and epitopes of Mycobacterium tuberculosis protein MPT64 (Rv1980c) and their recognition by human Th1 cells. doi:10.1159/000316375 names it Med Princ Pract 2010
Comparison of antibody responses to seventeen antigens from Mycobacterium tuberculosis. doi:10.1016/j.cca.2010.06.014 Clin Chim Acta 2010
Evaluation of Mycobacterium tuberculosis specific RD antigens for delayed type hypersensitivity responses in guinea pig. Indian J Exp Biol 2010
Mapping of Th1-cell epitope regions of Mycobacterium tuberculosis protein MPT64 (Rv1980c) using synthetic peptides and T-cell lines from M. tuberculosis-infected healthy humans. doi:10.1159/000273073 names it Med Princ Pract 2010
Peptides from the Mycobacterium tuberculosis Rv1980c protein involved in human cell infection: insights into new synthetic subunit vaccine candidates. doi:10.1515/bc.2010.019 names it Biol Chem 2010
Mycobacterium smegmatis expressing a chimeric protein MPT64-proteolipid protein (PLP) 139-151 reorganizes the PLP-specific T cell repertoire favoring a CD8-mediated response and induces a relapsing experimental autoimmune encephalomyelitis. doi:10.4049/jimmunol.0804263 names it J Immunol 2010
Utility of a combination of RD1 and RD2 antigens as a diagnostic marker for tuberculosis. doi:10.1016/j.diagmicrobio.2009.09.005 Diagn Microbiol Infect Dis 2010
[Identification of the Mycobacterium tuberculosis complex by detecting recombinant secretory protein MPT64]. names it Zhonghua Jie He He Hu Xi Za Zhi 2009
[Dimo-thylidioctyl ammonium bromide-BCG polysaccharide nucleic acid adjuvant enhanced the immunogenicity of a Mycobacterium tuberculosis subunit vaccine]. Zhonghua Jie He He Hu Xi Za Zhi 2009
Use of an immunochromatographic kit for the rapid detection of Mycobacterium tuberculosis from broth cultures. Int J Tuberc Lung Dis 2009
Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice. doi:10.1016/j.vaccine.2009.08.018 names it Vaccine 2009
HLA-promiscuous Th1-cell reactivity of MPT64 (Rv1980c), a major secreted antigen of Mycobacterium tuberculosis, in healthy subjects. doi:10.1159/000226293 names it Med Princ Pract 2009
Novel recombinant RD2- and RD11-encoded Mycobacterium tuberculosis antigens are potential candidates for diagnosis of tuberculosis infections in BCG-vaccinated individuals. doi:10.1016/j.micinf.2009.05.008 Microbes Infect 2009
Compartmentalization of immune responses in human tuberculosis: few CD8+ effector T cells but elevated levels of FoxP3+ regulatory t cells in the granulomatous lesions. doi:10.2353/ajpath.2009.080941 Am J Pathol 2009
More vaccine efficacy studies on the recombinant Bacille Calmette-Guerin co-expressing Ag85B, Mpt64 and Mtb8.4. doi:10.1111/j.1365-3083.2009.02231.x names it Scand J Immunol 2009
The selection and application of ssDNA aptamers against MPT64 protein in Mycobacterium tuberculosis. doi:10.1515/CCLM.2009.097 names it Clin Chem Lab Med 2009
An improved whole-blood gamma interferon assay based on the CFP21-MPT64 fusion protein. doi:10.1128/CVI.00486-08 names it Clin Vaccine Immunol 2009
[Immunoprophylaxis of recombinant Mycobacterium vaccae secreted MPT64 of Mycobacterium tuberculosis]. names it Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2009
Evaluation of an immunochromatographic assay kit for rapid identification of Mycobacterium tuberculosis complex in clinical isolates. doi:10.1128/JCM.01253-08 J Clin Microbiol 2009
Discovery of stable and variable differences in the Mycobacterium avium subsp. paratuberculosis type I, II, and III genomes by pan-genome microarray analysis. doi:10.1128/AEM.01683-08 Appl Environ Microbiol 2009
Immunoreactivity of five antigens of Mycobacterium tuberculosis in patients attending a public health care facility in an area with high endemicity for TB. doi:10.1111/j.1348-0421.2008.00072.x Microbiol Immunol 2008
[Selecting and affinity analysis of DNA aptamers to MPT64 protein from Mycobacterium tuberculosis]. names it Zhonghua Jie He He Hu Xi Za Zhi 2008
Rapid and specific diagnosis of tuberculous pleuritis with immunohistochemistry by detecting Mycobacterium tuberculosis complex specific antigen MPT64 in patients from a HIV endemic area. doi:10.1097/PAI.0b013e31816c3f79 names it Appl Immunohistochem Mol Morphol 2008
Cell-mediated immune responses to complex and single mycobacterial antigens in tuberculosis patients with diabetes. doi:10.1159/000129614 Med Princ Pract 2008
Efficacy of recombinant bacille Calmette-Guérin vaccine secreting interleukin-15/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis. doi:10.1086/586902 J Infect Dis 2008
The tuberculin skin test increases the responses measured by T cell interferon-gamma release assays. doi:10.1111/j.1365-3083.2008.02103.x Scand J Immunol 2008
Expression and purification of Mycobacterium tuberculosis ESAT-6 and MPT64 fusion protein and its immunoprophylactic potential in mouse model. doi:10.1016/j.pep.2007.11.016 names it Protein Expr Purif 2008
Efficient tuberculosis treatment in mice using chemotherapy and immunotherapy with the combined DNA vaccine encoding Ag85B, MPT-64 and MPT-83. doi:10.1038/gt.2008.13 Gene Ther 2008
Differential expression of mycobacterial antigen MPT64, apoptosis and inflammatory markers in multinucleated giant cells and epithelioid cells in granulomas caused by Mycobacterium tuberculosis. doi:10.1007/s00428-008-0575-z names it Virchows Arch 2008
Evaluation of a new recombinant BCG which contains mycobacterial antigen ag85B-mpt64(190-198)-mtb8.4 in C57/BL6 mice. doi:10.1111/j.1365-3083.2007.02048.x names it Scand J Immunol 2008
Immunohistochemical diagnosis of abdominal and lymph node tuberculosis by detecting Mycobacterium tuberculosis complex specific antigen MPT64. doi:10.1186/1746-1596-2-36 names it Diagn Pathol 2007
Identification of novel bacterial plasminogen-binding proteins in the human pathogen Mycobacterium tuberculosis. doi:10.1002/pmic.200600876 Proteomics 2007
Supplementation with RD antigens enhances the protective efficacy of BCG in tuberculous mice. doi:10.1016/j.clim.2007.07.007 Clin Immunol 2007
Reduced apoptosis and increased inflammatory cytokines in granulomas caused by tuberculous compared to non-tuberculous mycobacteria: role of MPT64 antigen in apoptosis and immune response. doi:10.1111/j.1365-2249.2007.03476.x names it Clin Exp Immunol 2007
Interferon gamma response to combinations 38 kDa/CFP-10, 38 kDa/MPT-64, ESAT-6/MPT-64 and ESAT-6/CFP-10, each related to a single recombinant protein of Mycobacterium tuberculosis in individuals from tuberculosis endemic areas. doi:10.1111/j.1348-0421.2007.tb03910.x Microbiol Immunol 2007
H2-M3-restricted CD8+ T cells induced by peptide-pulsed dendritic cells confer protection against Mycobacterium tuberculosis. doi:10.4049/jimmunol.178.6.3806 J Immunol 2007
Chitosan microspheres enhance the immunogenicity of an Ag85B-based fusion protein containing multiple T-cell epitopes of Mycobacterium tuberculosis. doi:10.1016/j.ejpb.2006.11.028 Eur J Pharm Biopharm 2007
Immunotherapy for orthotopic murine bladder cancer using bacillus Calmette-Guerin recombinant protein Mpt-64. doi:10.1016/j.juro.2006.09.074 J Urol 2007
The solution structure of antigen MPT64 from Mycobacterium tuberculosis defines a new family of beta-grasp proteins. doi:10.1016/j.jmb.2006.11.039 names it J Mol Biol 2007
Spoligotyping of Mycobacterium tuberculosis DNA from Archival Ziehl-Neelsen-stained sputum smears. doi:10.1016/j.mimet.2006.09.001 J Microbiol Methods 2007
Immunohistochemistry using a Mycobacterium tuberculosis complex specific antibody for improved diagnosis of tuberculous lymphadenitis. doi:10.1038/modpathol.3800697 Mod Pathol 2006
A combined DNA vaccine-prime, BCG-boost strategy results in better protection against Mycobacterium bovis challenge. doi:10.1089/dna.2006.25.438 DNA Cell Biol 2006
Disease state differentiation and identification of tuberculosis biomarkers via native antigen array profiling. doi:10.1074/mcp.M600089-MCP200 Mol Cell Proteomics 2006
Cytokine profiles in tuberculosis patients and healthy subjects in response to complex and single antigens of Mycobacterium tuberculosis. doi:10.1111/j.1574-695X.2006.00110.x FEMS Immunol Med Microbiol 2006
Design and optimization of a recombinant system for large-scale production of the MPT64 antigen from Mycobacterium tuberculosis. doi:10.1016/j.pep.2005.08.011 names it Protein Expr Purif 2006
Antibody response to four secretory proteins from Mycobacterium tuberculosis and their complex antigen in TB patients. Int J Tuberc Lung Dis 2005
Integration of microscopy and serodiagnostic tests to screen for active tuberculosis. Int J Tuberc Lung Dis 2005
Coadministration of interleukin 2 plasmid DNA with combined DNA vaccines significantly enhances the protective efficacy against Mycobacterium tuberculosis. doi:10.1089/dna.2005.24.605 DNA Cell Biol 2005
NMR assignment of protein Rv1980c from Mycobacterium tuberculosis. doi:10.1007/s10858-005-1202-9 names it J Biomol NMR 2005
Improved diagnostic value of PCR in the diagnosis of female genital tuberculosis leading to infertility. doi:10.1099/jmm.0.45943-0 J Med Microbiol 2005
Pharmacoproteomic effects of isoniazid, ethambutol, and N-geranyl-N'-(2-adamantyl)ethane-1,2-diamine (SQ109) on Mycobacterium tuberculosis H37Rv. doi:10.1124/jpet.105.087817 J Pharmacol Exp Ther 2005
Therapeutic effects of Ag85B and MPT64 DNA vaccines in a murine model of Mycobacterium tuberculosis infection. doi:10.1016/j.vaccine.2005.05.035 names it Vaccine 2005
[Immunogenicity and protection of divalent DNA vaccine encoding antigens MPT83 and MPT64 of Mycobacterium tuberculosis]. names it Zhonghua Yi Xue Za Zhi 2005
Combined DNA vaccines formulated either in DDA or in saline protect cattle from Mycobacterium bovis infection. doi:10.1016/j.vaccine.2005.03.025 Vaccine 2005
Peripheral blood and pleural fluid mononuclear cell responses to low-molecular-mass secretory polypeptides of Mycobacterium tuberculosis in human models of immunity to tuberculosis. doi:10.1128/IAI.73.6.3547-3558.2005 Infect Immun 2005
Combined DNA vaccine encapsulated in microspheres enhanced protection efficacy against Mycobacterium tuberculosis infection of mice. doi:10.1016/j.vaccine.2005.03.024 Vaccine 2005
Human immune recognition-based multicomponent subunit vaccines against tuberculosis. doi:10.1183/09031936.05.00105404 Eur Respir J 2005
IgA antibody responses to Mycobacterium tuberculosis recombinant MPT-64 and MT-10.3 (Rv3019c) antigens in pleural fluid of patients with tuberculous pleurisy. Int J Tuberc Lung Dis 2005
[A study of the protective effect of the DNA vaccine encoding tubercle antigen 85B with MPT64 in mice challenged with Mycobacterium tuberculosis]. names it Zhonghua Jie He He Hu Xi Za Zhi 2004
Epitope DNA vaccines against tuberculosis: spacers and ubiquitin modulates cellular immune responses elicited by epitope DNA vaccine. doi:10.1111/j.0300-9475.2004.01442.x Scand J Immunol 2004
Protection of mice with a divalent tuberculosis DNA vaccine encoding antigens Ag85B and MPT64. doi:10.1093/abbs/36.4.269 names it Acta Biochim Biophys Sin (Shanghai) 2004
[The estimation of protective efficacy of the fusion gene vaccine encoding tubercle antigen 85B and MPT64 in mice challenged with Mycobacterium tuberculosis]. names it Zhonghua Yi Xue Za Zhi 2004
[Immunogenicity of DNA vaccine encoding fusion protein of Mycobacterium tuberculosis Ag85B and MPT64]. names it Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2003
Immunogenicity and protective efficacy study using combination of four tuberculosis DNA vaccines. doi:10.1360/02yc0121 Sci China C Life Sci 2003
Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adults. doi:10.1128/cdli.10.4.602-611.2003 Clin Diagn Lab Immunol 2003
Coexpression of interleukin-12 chains by a self-splicing vector increases the protective cellular immune response of DNA and Mycobacterium bovis BCG vaccines against Mycobacterium tuberculosis. doi:10.1128/IAI.70.4.1949-1956.2002 Infect Immun 2002
Induction of CD8+ T-lymphocyte responses to a secreted antigen of Mycobacterium tuberculosis by an attenuated vaccinia virus. doi:10.1046/j.1440-1711.2001.01042.x Immunol Cell Biol 2001
[Evaluation of protective efficacy of two tuberculosis DNA vaccines by lung histopathological analysis]. Zhonghua Yu Fang Yi Xue Za Zhi 2001
Dendritic cells infected with Mycobacterium bovis bacillus Calmette Guerin activate CD8(+) T cells with specificity for a novel mycobacterial epitope. doi:10.1093/intimm/13.4.451 Int Immunol 2001
Preparation of Culture Filtrate Proteins from Mycobacterium tuberculosis. doi:10.1385/1-59259-147-7:205 Methods Mol Med 2001
DNA vaccination against tuberculosis: expression of a ubiquitin-conjugated tuberculosis protein enhances antimycobacterial immunity. doi:10.1128/IAI.68.6.3097-3102.2000 Infect Immun 2000
The immunogenicity of single and combination DNA vaccines against tuberculosis. doi:10.1016/s0264-410x(99)00540-x Vaccine 2000
Tuberculin-purified protein derivative-, MPT-64-, and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and in patients with tuberculosis. doi:10.1128/CDLI.6.6.934-937.1999 Clin Diagn Lab Immunol 1999
Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences. doi:10.1128/IAI.67.9.4780-4786.1999 Infect Immun 1999
A mouse model for slowly progressive primary tuberculosis. doi:10.1046/j.1365-3083.1999.00596.x Scand J Immunol 1999
Co-immunization with DNA vaccines expressing granulocyte-macrophage colony-stimulating factor and mycobacterial secreted proteins enhances T-cell immunity, but not protective efficacy against Mycobacterium tuberculosis. doi:10.1046/j.1365-2567.1999.00703.x Immunology 1999
Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis. doi:10.1128/IAI.67.4.1702-1707.1999 Infect Immun 1999
A historical and molecular phylogeny of BCG strains. doi:10.1016/s0264-410x(98)00277-1 Vaccine 1999
Differential T cell responses to Mycobacterium tuberculosis ESAT6 in tuberculosis patients and healthy donors. doi:10.1002/(SICI)1521-4141(199812)28:12<3949::AID-IMMU3949>3.0.CO;2-4 Eur J Immunol 1998
Comparison of antigen-specific T-cell responses of tuberculosis patients using complex or single antigens of Mycobacterium tuberculosis. doi:10.1046/j.1365-3083.1998.00419.x Scand J Immunol 1998
Delayed-type hypersensitivity responses to ESAT-6 and MPT64 from Mycobacterium tuberculosis in the guinea pig. doi:10.1128/IAI.66.7.3454-3456.1998 names it Infect Immun 1998
B-cell epitopes and quantification of the ESAT-6 protein of Mycobacterium tuberculosis. doi:10.1128/IAI.66.2.717-723.1998 Infect Immun 1998
Characterization of the delayed type hypersensitivity-inducing epitope of MPT64 from Mycobacterium tuberculosis. doi:10.1046/j.1365-3083.1997.d01-429.x names it Scand J Immunol 1997
Physical mapping of Mycobacterium bovis BCG pasteur reveals differences from the genome map of Mycobacterium tuberculosis H37Rv and from M. bovis. doi:10.1099/13500872-142-11-3135 Microbiology (Reading) 1996
Clinical evaluation of MPT-64 and MPT-59, two proteins secreted from Mycobacterium tuberculosis, for skin test reagents. doi:10.1016/s0962-8479(96)90009-x Tuber Lung Dis 1996
Human T-cell epitopes on the Mycobacterium tuberculosis secreted protein MPT64. doi:10.1046/j.1365-3083.1996.d01-260.x names it Scand J Immunol 1996
Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. doi:10.1128/jb.178.5.1274-1282.1996 J Bacteriol 1996
Expression of Mycobacterium tuberculosis MPT64 in recombinant Myco. smegmatis: purification, immunogenicity and application to skin tests for tuberculosis. doi:10.1046/j.1365-2249.1996.d01-613.x names it Clin Exp Immunol 1996
Mapping of the delayed-type hypersensitivity-inducing epitope of secreted protein MPT64 from Mycobacterium tuberculosis. doi:10.1128/iai.63.12.4613-4618.1995 names it Infect Immun 1995
Guinea pig cellular immune responses to proteins secreted by Mycobacterium tuberculosis. doi:10.1128/iai.63.3.804-810.1995 Infect Immun 1995
Delayed-type hypersensitivity to a recombinant mycobacterial antigen, MPB64, in guinea pigs sensitized to Mycobacterium tuberculosis or Mycobacterium bovis BCG. doi:10.1002/jlb.57.2.221 J Leukoc Biol 1995
Cloning and B-cell-epitope mapping of MPT64 from Mycobacterium tuberculosis H37Rv. doi:10.1128/iai.62.5.2058-2064.1994 names it Infect Immun 1994
Evidence for absence of the MPB64 gene in some substrains of Mycobacterium bovis BCG. doi:10.1128/iai.61.5.1730-1734.1993 Infect Immun 1993
Identification of a novel 27-kDa protein from Mycobacterium tuberculosis culture fluid by a monoclonal antibody specific for the Mycobacterium tuberculosis complex. doi:10.1111/j.1365-3083.1993.tb03321.x Scand J Immunol 1993
Heterogeneity of monoclonal antibody-reactive epitopes on mycobacterial 30-kilodalton-region proteins and the secreted antigen 85 complex and demonstration of antigen 85B on the Mycobacterium leprae cell wall surface. doi:10.1128/iai.60.12.5172-5181.1992 Infect Immun 1992
Identification and characterization of epitopes shared between the mycobacterial 65-kilodalton heat shock protein and the actively secreted antigen 85 complex: their in situ expression on the cell wall surface of Mycobacterium leprae. doi:10.1128/iai.60.11.4517-4527.1992 Infect Immun 1992
A family of cross-reacting proteins secreted by Mycobacterium tuberculosis. doi:10.1111/j.1365-3083.1992.tb03104.x Scand J Immunol 1992

Title+abstract index only: a paper that names this gene solely in its body text, a figure legend or a supplement is invisible here. That is why this list sits beside the curated layer rather than replacing it - Rv0007's characterisation, found by a full-text sweep, returns zero in this one. Absence from this list is not absence from the literature. Source: PubMed E-utilities sweep (esearch + esummary), every alias of the gene searched in conjunction with a mycobacterial context term; ambiguous common-word aliases excluded. phase198, 2026-09-06.

This layer CITES the literature and adds context; it does not change the verdict or the function stated elsewhere in this fiche. This distinguishes a gene that is dark because nobody has looked from one that is dark despite having been studied. Source: PubMed (whole): H37Rv locus tag + GENE NAME + ortholog identifiers (Mb…, MMAR_…, MSMEG_…, ML…, MAB_…), under a mycobacterial context filter; hits verified against the abstract text. Species-context counts distinguish M. tuberculosis literature from literature on other mycobacteria. phase76/phase77, 2026-07-13.

CRISPRi vulnerability

Vulnerability index 1.10 (95% CI -0.58 to 3.86). A more negative index = more vulnerable to knockdown (better drug-target quality); indicative threshold VI ≤ -6 = highly vulnerable.

Quantitative CRISPRi knockdown, graded (finer than binary Tn-seq essentiality). Source: CRISPRi vulnerability index (Bosch 2021, supplementary Table S2 'mmc3.xlsx', bulk import via Europe PMC -- supersedes the per-gene pebble.rockefeller.edu scrape of phase46_crispri_vulnerability.py).

Caveat on this estimate. Bosch et al. flag this gene's vulnerability estimate as NOT certain, and here that call has a mechanical cause visible in the library itself: every guide targeting this gene is >=21 nt (str_span=0.258 on a 0-1 scale, near the genome floor), and guide repression strength saturates from 21 nt on -- so the library never sampled a partial knockdown for this gene, only the near-maximal repression plateau. The dose-response fit (and this VI) is therefore essentially unconstrained by data, not merely uncertain -- a limitation of the CRISPRi library design for the non-essential class (Bosch et al. 2021), not a defect in this specific measurement. n_guides=7 is descriptive only and does not predict this. Do not cite this VI as a standalone vulnerability claim.

Orthologues (reciprocal best hits across mycobacteria)

M. bovis Mb2002c · 100.0% identity
M. marinum MMAR_5409 · 65.8% identity
M. orygis RJtmp_002042 · 100.0% identity
M. abscessus MAB_1835c · 43.9% identity

Reciprocal-best-hit orthologues (DIAMOND) against the Mycobrowser reference proteomes. A missing species is informative: e.g. a gene absent from M. leprae was likely lost in its reductive genome evolution. Locus tags link to Mycobrowser.

Curated reference (UniProt)

UniProt P9WIN9 SwissProt · reviewed · Evidence at protein level
UniProt nameImmunogenic protein MPT64

Functional vocabulary (eggNOG-mapper, orthology transfer)

COG category S Function unknown
Preferred namempt64
eggNOG descriptionProtein of unknown function (DUF3298)
Orthologous group28KR0
Gene Ontology (27) GO:0003674, GO:0005488, GO:0005515, GO:0005575, GO:0005576, GO:0005618, GO:0005623, GO:0006950, GO:0007154, GO:0008150, GO:0009267, GO:0009605 +15 more

Orthology-based transfer (eggNOG 5.0.2, diamond). EC/KO/GO/CAZy are computed annotations, not manual curation; cross-check against the primary literature before treating a specific reaction as established.

Conservation & selection (intra-MTBC, 142 601 strains, snapshot of 2026-09-29)

pN/pS 0.521 · relaxed/neutral
Polymorphic sites (≥ 0.1% of strains) 3 synonymous, 5 missense, 0 nonsense, 0 frameshift

pN/pS from segregating SNPs (singletons removed) normalised by possible sites. Low pN/pS = purifying selection (a strong signal that a "hypothetical" is a real, constrained gene). A high pN/pS is ambiguous: relaxed constraint or positive selection (drug resistance, antigenic variation) inflate it; e.g. rpoB/katG/pncA score high here for resistance, not loss of function. A clonal disruption (one allele over a clade) suggests lineage pseudogenisation; a convergent one (many independent alleles) is typical of resistance loss-of-function.

Outgroup conservation (beyond the MTBC) Mycobacteriaceae

M. canettii dN/dS (deep-divergence selection) undefined (dS = 0) (low power) · 1 consensus substitution(s)
low power (1 canettii-consensus substitution(s)); present in M. canettii but dN/dS not reliable
Limitation: dN/dS mixes fixed canettii-H37Rv divergence with intra-canettii polymorphism, and is not polarised (the per-gene repolarisation is not viable: 79 % of the consensus SPDI lie outside the polarised table).
Genus-wide presence (~53 non-MTBC Mycobacterium) present in 52/53 (98%) · mean identity 52.8% · 4/4 closest MTBAP relatives
conserved across the genus (present in 52/53 non-MTBC Mycobacterium genomes, incl. distant relatives) — an ancient core gene predating the genus radiation
Phylostratum (deepest detected homolog) MTBC-specific → Mycobacterium → Mycobacteriaceae → Corynebacteriales → Actinomycetia → Bacteria
detected in 1/13 non-Mycobacterium reference genomes (down to Mycobacteriaceae) · mean identity 43.7%
detected in the sister family Mycobacteriaceae (M. abscessus) but not in the broader Corynebacteriales — a Mycobacteriaceae-restricted gene (single-genome rung: interpret with care)

Two orthogonal outgroup signals. M. canettii (the immediate outgroup) gives a deep-divergence dN/dS (a low value confirms a constrained, real gene; shown as confident only at ≥8 substitutions, else flagged low-power). Genus-wide presence/absence (tblastn vs assembled non-MTBC genomes) places the gene on the ancient-core ↔ MTBC-specific axis: a gene absent even from the closest MTBAP relatives is a candidate MTBC-specific innovation (possible host-adaptation factor, to confirm by synteny). The phylostratum extends that axis outside the genus (tblastn vs 13 reference genomes spanning Mycobacteriaceae → Corynebacteriales → Actinomycetia → outside the phylum): it is the deepest clade in which a homolog is still detected, i.e. a proxy for gene age. Read it with the null model in mind: a shallow (young) stratum can also reflect homology-detection failure for short or fast-evolving ORFs, so it is a descriptive axis, not a proof of novelty.

Essentiality (transposon mutagenesis)

DeJesus 2017 callGA · growth-advantage
What the call meansgrowth-advantage: insertions enriched
TA sites (Himar1) 20 in the ORF — 0 in the essential state, 0 growth-defect, 0 non-essential, 20 growth-advantage. Saturation 1.000, mean read count 269.45. A region of the protein devoid of TA sites is invisible to this assay: nothing can be inferred about it, in either direction.
All 20 sites lie in this ORF alone (no overlapping CDS shares any), so the call is attributable to this gene.

Genome-wide Himar1 transposon essentiality in H37Rv (DeJesus 2017). An essential call (ES/ESD/GD) is strong, independent evidence that a "hypothetical" locus encodes a functional, selectively required gene — orthogonal to intra-species conservation.

Mutant phenotypes (conditional Tn-seq, MtbTnDB) in-vivo phenotype

Conditionlog2FCqEffect
fitness in mouse infection (in vivo) +1.120.0094 disruption advantageous

Conditional fitness of transposon-disruption mutants across 1 significant condition(s) (|log2FC|≥1, q≤0.05), from the standardized MtbTnDB compendium. A negative log2FC means the mutant is depleted — the gene contributes to fitness in that condition. An in-vivo defect for a "hypothetical" is strong evidence it matters for infection, even without a known molecular function. Disruption (Tn insertion), not a clean deletion; genetic-interaction screens excluded.

Proteomics (mass spectrometry) detected

MS detectiondetected in 16 of 16 independent MS datasets
Integrated abundance2552.0 ppm · rank 50/3519 (98.6th percentile)

Detection by mass spectrometry is direct, experimental evidence that the protein product exists — orthogonal to sequence conservation and to Tn-seq essentiality, and especially decisive for a "hypothetical" locus. Read the dataset count as abundance, not as replication. Measured across this atlas (3,491 detected proteins), the number of datasets a protein appears in tracks its abundance almost monotonically: median 1.2 ppm at 1 dataset of 16, 27 ppm at 10, 392 ppm at 15, 1,325 ppm at 16 — three orders of magnitude. A high count therefore says the protein is abundant more than it says several independent experiments confirmed it. What the count does establish, at any value, is that the product exists.

Predicted localisation (DeepTMHMM + lipobox) signal peptide

Predictionpredicted secreted protein (signal peptide)
DeepTMHMM classSP

Transmembrane topology and signal peptide from DeepTMHMM (deep-learning reference predictor); lipoproteins from a (myco)bacterial lipobox motif. A sequence-based prediction of subcellular context.

Physico-chemical properties (computed, ProtParam)

Length228 aa
Molecular weight24.9 kDa
Theoretical pI4.84
GRAVY-0.137 (hydrophilic)
Aliphatic index82.2
Aromaticity0.096
Instability index28.7 (stable)

Computed from the ancestral MTBC0 sequence with the ExPASy ProtParam method (Biopython). Descriptive biophysical context: a positive GRAVY flags a hydrophobic (often membrane) protein, a high instability index (>40) predicts a short in-vitro half-life, an extreme pI hints at compartment or binding partner.

Domains (Pfam, hmmscan --cut_ga)

PfamAccessioni-EvalueResiduesDescription
DUF3298PF11738.14 1.6e-16146–221 Protein of unknown function (DUF3298)

3D structure (interactive — Mol*/pdbe-molstar)

Experimental structure 2hhi (PDBe), the strongest available structural evidence for this gene. Drag to rotate, scroll to zoom; hetero-groups (ligands, ions, waters hidden by default) shown as sticks.

Experimental structures (Protein Data Bank) 1 solved

PDBMethodResolutionCoverage
2hhi Solution NMR — 99%

Experimentally solved structures mapped from the UniProt accession via PDBe/SIFTS (1 total; up to 8 shown, ranked by sequence coverage then resolution). An experimental structure is direct proof of the folded product and the strongest structural evidence — superseding the predicted ESMFold/AlphaFold models below for any covered region.

Structural search (AlphaFold DB model, Foldseek vs PDB — genome-wide) pLDDT 87.7

PDB hitprobTM (aln)TM (query)TM (target)Seq. id.Cov. q / tE-valueDescription
2hhi-assembly1_A 1.00 0.63 0.58 0.63 100% 90% / 100% 9.9e-28 sig 2hhi-assembly1_A The solution structure of antigen MPT64 from Mycobacterium tuberculosis defines a novel class of beta-grasp proteins
3cyg-assembly2_A 1.00 0.70 0.64 0.67 16% 82% / 91% 1.2e-11 sig 3cyg-assembly2_A Crystal structure of an uncharacterized protein from Fervidobacterium nodosum Rt17-B1
3cyg-assembly3_B 1.00 0.72 0.62 0.72 18% 82% / 97% 1.2e-10 sig 3cyg-assembly3_B Crystal structure of an uncharacterized protein from Fervidobacterium nodosum Rt17-B1
5jen-assembly2_C 1.00 0.65 0.58 0.64 13% 82% / 93% 1.1e-09 sig 5jen-assembly2_C Crystal structure of the anti-sigma factor RsiV bound to lysozyme
5jen-assembly1_A 1.00 0.62 0.56 0.59 15% 82% / 93% 2.1e-10 sig 5jen-assembly1_A Crystal structure of the anti-sigma factor RsiV bound to lysozyme

Foldseek search of the AlphaFold DB model (mean pLDDT 87.7, gated at 70) against the PDB — a genome-wide extension of the ESMFold dark-gene search that also covers proteins beyond the single-sequence length limit. Confident structural neighbours (E < 0.01) shown.

Genomic context (neighbours & predicted operon)

Upstream (5' on genome)Rv1979c (- strand, 178 bp gap)
Downstream (3' on genome)nrdF1 (- strand, 190 bp gap)

Neighbours from the H37Rv annotation (- strand). The operon is predicted by co-directional intergenic distance (same strand, gaps ≤50 bp) — a transcription-unit hypothesis, not a mapped TSS. For a "hypothetical", co-transcription with a characterised operon is a concrete functional lead (complements the STRING neighborhood channel below).

Published operon evidence (two independent sources)

Roback 2007 (logistic regression: distance + expression correlation, 474 microarrays) no multi-gene operon predicted (singleton)
REMap 2016 (RNA-seq coverage continuity, CDC1551, tag MT2032) exponential phase: operon of 5, Rv1979c · Rv1980c · Rv1981c · Rv1982A · Rv1982c (coverage 583.64)
stationary phase: operon of 4, Rv1980c · Rv1981c · Rv1982A · Rv1982c (coverage 372.45) — disagrees with the distance heuristic above

Two independent published operon maps, cited alongside the distance heuristic above: an association corroborating or contradicting the heuristic, never proof of shared function. REMap's RNA-seq coverage continuity is the most direct of the three signals; Roback's logistic regression and the intergenic-distance heuristic are statistical proxies.

Functional interaction network (STRING v12, guilt-by-association)

Explore full network →

Node colour = verdict, dashed = still uncharacterised; edge colour = evidence (green experimental, orange genomic-context, grey co-expression), width ∝ score. Click a partner to open its page; "Explore full network" to walk the graph.

Closest characterised functional partner: Rv1979c (permease), medium confidence (score 569, all STRING channels except text-mining; the partner is chosen on its genomic-context evidence).

Showing the 15 strongest of this gene's 34 partners at medium confidence (15 at high confidence). The table is an extract, not a neighbourhood: across the proteome the real median degree is 34 while the served median is 15, so no hub, degree distribution or centrality may be read on this table. None of the 34 partners rests on an interaction measured in M. tuberculosis itself.

PartnerProductScoreNo text-miningChannels (≥400)
Rv1979c permease 735 569 ctx neighborhood:475 textmining:411
Rv1981c nrdF1 ribonucleoside-diphosphate reductase subunit beta NrdF1 864 476 ctx neighborhood:468 textmining:752
Rv3804c fbpA diacylglycerol acyltransferase/mycolyltransferase Ag85A 855 65 textmining:852
Rv0934 pstS1 phosphate ABC transporter substrate-binding lipoprotein PstS 853 55 textmining:852
Rv0667 rpoB DNA-directed RNA polymerase subunit beta 507 55 textmining:500
Rv2945c lppX lipoprotein LppX 487 55 textmining:480
Rv1876 bfrA bacterioferritin BfrA 434 55 textmining:426
Rv2376c cfp2 low molecular weight antigen MTB12 545 54 textmining:540
Rv2878c mpt53 soluble secreted antigen Mpt53 462 52 textmining:457
Rv1886c fbpB diacylglycerol acyltransferase/mycolyltransferase Ag85B 936 51 textmining:936
Rv1984c cfp21 cutinase 809 51 textmining:807
Rv3418c groES chaperonin GroES 771 50 textmining:770
Rv0288 esxH ESAT-6-like protein EsxH 553 50 textmining:549
Rv3875 esxA ESAT-6 protein EsxA 926 47 textmining:926
Rv0350 dnaK chaperone protein DnaK 787 47 textmining:786

STRING combines evidence channels (neighborhood, fusion, cooccurrence, coexpression, experimental, database, text-mining) into a 0–1000 score. The ctx badge marks edges carried by the genomic-context channels (conserved neighborhood, fusion, phylogenetic co-occurrence), which are independent of orthology and structure and the strongest signal for an unknown gene. The no text-mining column recomputes the score from data alone, so a link that does not depend on the literature is visible. Association is a function hypothesis, not proof: corroborate with the operon context and the primary literature before assigning a function.

Where the experimental evidence comes from, and why it matters here. STRING's experimental channel fuses interactions measured in M. tuberculosis with interactions measured in another organism and transferred to this pair by orthology. The two are not equivalent for this atlas, whose standing rule is that better studied elsewhere is not a function established in M. tuberculosis. Measured on the served network: of the 38 229 partner pairs shown across the atlas, 13 483 partner rows carry a non-zero experimental channel, and only 106 pairs rest on an interaction measured in M. tuberculosis itself — 0.3 % of the network. Those 106 are long-established complexes (ESX-1/ESAT-6, RNA polymerase with CarD and RbpA, the Pup–Mpa proteasome, gyrase, Emb, GarA with PknB and PknG, the Rel modules); no still-uncharacterised gene is among them. The reason is not a gap in this atlas but in the literature: there is almost no experimental interactome of this bacterium, IntAct holding 134 curated protein pairs for a ~4 000-gene proteome. A exp (transferred) badge is therefore a lead, never a measurement, and an absence of badge is not evidence that the pair does not interact.

Evidence

  • Legacy H37Rv annotation: immunogenic protein Mpt64
  • MTBC0 PGAP product: immunoprotective protein Mpt64
  • Pfam (hmmscan --cut_ga): DUF3298 PF11738.14 (E=2e-16)
  • (auto-curated by rules from PGAP + Pfam + Foldseek; not hand-reviewed)

Sources

  • Ancestral sequence & coordinates: Harrison LB et al. (2024), An imputed ancestral reference genome for the MTBC, doi:10.1101/2023.09.07.556366
  • Product annotation: NCBI PGAP on MTBC0; legacy from H37Rv NC_000962.3 (RefSeq NP_216496.1)
  • Domains: Pfam-A via hmmscan --cut_ga — DUF3298 (PF11738.14)
  • Sequence-level signal: ESM Atlas (EvolutionaryScale × BioHub) — exploratory
  • Controlled vocabulary: eggNOG-mapper 2.1.12 (Cantalapiedra et al. 2021, doi:10.1093/molbev/msab293), eggNOG 5.0 DB (Huerta-Cepas et al. 2019) — OG 28KR0
  • Curated reference: UniProt P9WIN9 (SwissProt, reviewed; Evidence at protein level)
  • Intra-MTBC selection: pN/pS and disruption from SPDI variants of 142 601 MTBC strains (this work, local collection vs H37Rv NC_000962.3)
  • Genome-wide structure: AlphaFold DB model (Jumper et al. 2021, doi:10.1038/s41586-021-03819-2; Varadi et al. 2024, doi:10.1093/nar/gkad1011) searched vs PDB with Foldseek (mean pLDDT 87.7)
  • Interaction network: STRING v12.0 (Szklarczyk et al. 2023, doi:10.1093/nar/gkac1000), taxon 83332, CC-BY 4.0 — 34 functional partner(s); context anchor Rv1979c
  • Essentiality: genome-wide transposon mutagenesis in H37Rv — DeJesus et al. 2017 (mBio, doi:10.1128/mBio.02133-16, CC BY)
  • Proteomics: integrated mass-spectrometry abundance from PaxDb 5.0 (Huang et al. 2023, doi:10.1016/j.mcpro.2023.100640), taxon 83332 — weighted average of 16 datasets, incl. Schubert et al. 2013 (doi:10.1016/j.chom.2013.04.008) and Albrethsen et al. 2013 (doi:10.1074/mcp.M112.018846)
  • Functional category: TubercuList scheme (Cole et al. 1998, doi:10.1038/31159), via Mycobrowser (Kapopoulou et al. 2011, doi:10.1016/j.tube.2010.09.006)
  • Orthologues: reciprocal best hits (DIAMOND, Buchfink et al. 2021, doi:10.1038/s41592-021-01101-x) against Mycobrowser release 5 reference proteomes
  • Experimental structures: PDBe/SIFTS UniProt→PDB mapping (Dana et al. 2019, doi:10.1093/nar/gky1114)
  • Genomic context / operon: H37Rv annotation; operon predicted by co-directional intergenic distance (Salgado et al. 2000, doi:10.1073/pnas.030539397)
  • Mutant phenotypes: standardized Tn-seq compendium MtbTnDB (Jinich et al. 2025, doi:10.1111/mmi.15370), aggregating many primary Tn-seq studies across conditions
  • Physico-chemical properties: ExPASy ProtParam method via Biopython (Gasteiger et al. 2005), computed from the MTBC0 sequence
  • Predicted localisation: DeepTMHMM (Hallgren et al. 2022, doi:10.1101/2022.04.08.487609) for transmembrane topology and signal peptide
  • Primary literature: none located yet; annotation rests on the domain/homology sources above.

Ancestral MTBC0 protein sequence

>mtbc0_002102|Rv1980c|mpt64
MRIKIFMLVTAVVLLCCSGVATAAPKTYCEELKGTDTGQACQIQMSDPAYNINISLPSYYPDQKSLENYIAQTRDKFLSAATSSTPREAPYELNITSATYQSAIPPRGTQAVVLKVYQNAGGTHPTTTYKAFDWDQAYRKPITYDTLWQADTDPLPVVFPIVQGELSKQTGQQVSIAPNAGLDPVNYQNFAVTNDGVIFFFNPGELLPEAAGPTQVLVPRSAIDSMLA